维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="SAAD ED"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase I study with pharmaco- kinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors 显示文摘	Hoff PM Saad ED Ajani JA	2003	Clin Cancer Res2003，9，1：	1
2	Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors 显示文摘	Hoff PM Saad ED Ajani JA	2003	Clin Can Res2003，9，1：	1
3	Case report:hand-foot syndrome induced by the oral fluoropyrimidine S-1显示文摘	Elasmar SA Saad ED Hoff PM	2001	Jpn Clin Onco2001，31，4：	1
4	Literature Review and Practical Aspects on the Management of Oxaliplat- in-Associated Toxicity显示文摘	Hoff PM Saad ED Costa F	2012	Clin Colorectal Cancer2012，11，2：	1
5	Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience显示文摘	Abushullaih S Saad ED Munsell M	2002	Cancer Invest2002，20，1：	1
6	Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience 显示文摘	Abushullaih S Saad ED Munsell M	2002	Cancer Invest2002，20，1：	1
7	Literature review and practical as- pects on the management of oxaliplatin associated toxicity 显示文摘	Hoff PM Saad ED Costa F	2012	Clinical Colorcctal Cancer2012，11，2：	1
8	Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine:a single-institution experience显示文摘	Saad ED Munsell M	2002	Cancer Invest2002，20，1：	1
9	Pretreatment CA 19- 9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemeitabine显示文摘	Saad ED Machado MC Wajsbrot D	2002	Int J Gastrointest Cancer2002，32，1：	1
10	Case report:hand-foot syndrome induced by the oral fluoropyrimidine S-I 显示文摘	ELASMAR SA SAAD ED HOFF PM	2001	Jpn Clin Oncol2001，31，4：	1
11	Cost -effectiveness of anastre- zole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil 显示文摘	Fonseca M Araajo GT Saad ED	2009	Rev Assoc Med Bras2009，55，4：	1
12	Molecular-targeted agents in pancreatic cancer 显示文摘	Saad ED Hoff PM	2004	Cancer Control2004，11，1：	1
13	Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitaine:a singel-institution experience显示文摘	Abushllaih S Saad ED Munsell M Hoff PM	2002	Cancer Invest2002，20，1：	1
14	Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine:a single-institution experience显示文摘	Abushullaih S Saad ED Munsell M	2002	Cancer Invest2002，20，：	1
15	Incidence and Severity of Hand-Foot Syndrome in Colorectal Cancer Patients Treated with Capecitabine:A Single-Institution Experience显示文摘	Abushullaih S Saad ED Munsell M et a1	2002	Cancer Invest2002，20，1：	1
16	Endobronchial findings of fibrosing mediastinitis显示文摘	Manali ED Saad CP Krizmanich G	2003	Respir Care2003，48，11：	1
17	Phase Ⅰ study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors显示文摘	Hoff PM Saad ED Ajani JA	2003	Clin Cancer Res2003，9，1：	1
18	Cost-effectiveness of anastro- zole, in comparison with tarnoxifen, in the adjuvant treatment of early breast cancer in Brazil 显示文摘	Fonseca M Araajo GT Saad ED	2009	RevAssoc Med Bras2009，55，4：	1
19	Literature review and practical aspects on the management of oxaliplatin associated toxicity 显示文摘	Hoff PM Saad ED Costa F	2012	Clin Colorectal Cancer2012，11，2：	1
20	Incidence and severity of hand- foot syndrome in culorectal cancer patients treated with capecitabine: a single - institution experience 显示文摘	Abushullaih S Saad ED Munsell M	2002	Cancer Invest2002，20，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示